User profiles for N. Bolli
Niccolo BolliUniversity of Milan Verified email at unimi.it Cited by 23823 |
Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?
After the discovery of NPM1-mutated acute myeloid leukemia (AML) in 2005 and its subsequent
inclusion as a provisional entity in the 2008 World Health Organization classification of …
inclusion as a provisional entity in the 2008 World Health Organization classification of …
Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications
… One is found within residues 94–102 with the sequence I-xx-P-xx-L-x-L 13 and the other at
the N-terminus within amino acids 42 to 49 (sequence L-x-L-xx-V-x-L), with leucines 42 and …
the N-terminus within amino acids 42 to 49 (sequence L-x-L-xx-V-x-L), with leucines 42 and …
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias
… In the encoded NPM-MLF1 fusion protein, the N-terminal portion of NPM is fused to almost
the entire MLF1 protein, excluding only the first 16 amino acids at the N-terminus96 (Figure 1B…
the entire MLF1 protein, excluding only the first 16 amino acids at the N-terminus96 (Figure 1B…
Signatures of mutational processes in human cancer
All cancers are caused by somatic mutations; however, understanding of the biological
processes generating these mutations is limited. The catalogue of somatic mutations from a …
processes generating these mutations is limited. The catalogue of somatic mutations from a …
[HTML][HTML] Genomic classification and prognosis in acute myeloid leukemia
…, NE Potter, M Heuser, F Thol, N Bolli… - … England Journal of …, 2016 - Mass Medical Soc
Background Recent studies have provided a detailed census of genes that are mutated in
acute myeloid leukemia (AML). Our next challenge is to understand how this genetic diversity …
acute myeloid leukemia (AML). Our next challenge is to understand how this genetic diversity …
[HTML][HTML] Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
… Two (n=13) or three (n=2) serial samples were available for 15 patients. Fifteen patients were
sampled … The fraction of cells bearing each mutation was then calculated as n mut /n chr . …
sampled … The fraction of cells bearing each mutation was then calculated as n mut /n chr . …
Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes
Introduction The human genome is peppered with mobile repetitive elements called long
interspersed nuclear element–1 (L1) retrotransposons. Propagating through RNA and cDNA …
interspersed nuclear element–1 (L1) retrotransposons. Propagating through RNA and cDNA …
[HTML][HTML] A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
… n = 784 dataset, since for this analysis, presence of ISS was not required. c OS in the same
set of patients (n = 863) … Note that this dataset is larger than the n = 784 dataset, since for this …
set of patients (n = 863) … Note that this dataset is larger than the n = 784 dataset, since for this …
Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer
… n = 49); mutations in the metastasis not found in the primary (n = 49); and shared mutations
(n … drift (VAF difference >0.2) between the two samples (n = 25). These data, particularly the …
(n … drift (VAF difference >0.2) between the two samples (n = 25). These data, particularly the …
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma
Understanding the profile of oncogene and tumor suppressor gene mutations with their
interactions and impact on the prognosis of multiple myeloma (MM) can improve the definition of …
interactions and impact on the prognosis of multiple myeloma (MM) can improve the definition of …